Who Paid My Doc
Sharon Thompson
Obstetrics & Gynecology Phoenix, AZ Medical Doctor
NPI 1265458897 CMS profile 102189
926 E McDowell Rd Ste 134, Phoenix, AZ 85006
General payments
$16,239
Research payments
$0
Ownership & investment interest
$0
Through program year 2023, Sharon Thompson of Phoenix, AZ is reported in the CMS Open Payments database as having received $16,239 across 6 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 97th percentile of Obstetrics & Gynecology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
2 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2023 | General | $15,439 | 5 | |
| 2022 | General | $800 | 1 |
Beside peers
- Sharon Thompson
- Obstetrics & Gynecology median
- Middle half of Obstetrics & Gynecology
- National median
In program year 2025, general payments to Sharon Thompson were reported at $0. Among 21,306 Obstetrics & Gynecology profiles paid that year, the median was $158 and the middle half received between $51 and $401.
Show as a table
| Year | Sharon Thompson | Obstetrics & Gynecology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $172 | $62–$391 | $163 |
| 2020 | $0 | $94 | $36–$222 | $114 |
| 2021 | $0 | $136 | $42–$369 | $132 |
| 2022 | $800 | $160 | $50–$433 | $149 |
| 2023 | $15,439 | $169 | $56–$423 | $160 |
| 2024 | $0 | $152 | $50–$371 | $164 |
| 2025 | $0 | $158 | $51–$401 | $169 |
Breakdown
Prescribing to Medicare patients
Part D · data year 2024 · 1 drugPart D claims
15
Drug cost
$483
Branded share of claims
100%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Valacyclovir Valacyclovir Hcl | Brand | 15 | $483 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 24,311 Part D prescribers listed as Obstetrics & Gynecology; they describe a distribution and say nothing about conduct.
Records
6 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Obstetrics & Gynecology in Arizona
Catherine Brainard
Obstetrics & Gynecology · Tucson, AZ
Micah Harris
Obstetrics & Gynecology · Scottsdale, AZ
Steven Nelson
Obstetrics & Gynecology · Phoenix, AZ
Ernesto Gomez
Obstetrics & Gynecology · Mesa, AZ
Bj Ho
Obstetrics & Gynecology · Phoenix, AZ
Chijioke Soribe
Obstetrics & Gynecology · Phoenix, AZ
Related records
Obstetrics & Gynecology in Arizona
Practitioners in the same specialty and state, ranked by reported value.
All Obstetrics & Gynecology
Everyone recorded under this specialty, nationwide.
Doctors in Arizona
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.